Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Nuclear Medicine Radioisotope Market by Radioisotope (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67), Fluorine-18, Rubidium-82 (Rb-82)) by Application (Oncology, Cardiology, Lymphoma, Thyroid, Neurology) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Nuclear Medicine Radioisotope Market was valued at USD XX Billion in the year 2017. Global Nuclear Medicine Radioisotope Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.

 

North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At the country level, U.S, India, and China are the major markets and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. The factors, such as well-established healthcare facilities, a growing geriatric population, rising awareness among people for nuclear medicine treatments and diagnosis, contribute to the growth of the regional market.

The Nuclear Medicine Radioisotope market is segmented on the basis of a type of radioisotope, application, and region. By type of radioisotope, Technetium-99m (Tc-99m) was the largest type segment of the Nuclear Medicine Radioisotopes market in 2017 and is expected to grow with XX% CAGR in coming years. Based on application, Cardiology was the largest type segment of the Nuclear Medicine Radioisotopes market in 2017

Drivers:

            Rising Incidences of Cancer and Cardiac Disorders

            Widening Applications of Nuclear Medicine

Restraints:

            Reimbursement Complications

Opportunities:

            Increasing Patient Awareness for Healthcare

Challenges:

            Strict government and regulatory environment 

Cardinal Health (US), GE Healthcare (US), and Curium (France) are the major players in the Global Nuclear Medicine Radioisotope Market. Other players involved in this market are Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India). Other players in the nuclear medicine market include Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India).

Key Benefits for Stakeholders

Nuclear Medicine Radioisotope manufacturers and retailers

Pharmaceutical and healthcare organizations

Industry associations

Government & Regulatory agencies and organizations

By Radioisotope

Technetium-99m (Tc-99m)

Thallium-201 (Tl-201)

Iodine (I-123)

Gallium-67 (Ga-67)

Fluorine-18

Rubidium-82 (Rb-82)

Other Types of Radioisotope

By Application

Oncology

Cardiology

Lymphoma

Thyroid

Neurology

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Cardinal Health

Ge Healthcare (A Fully-Owned Subsidiary of General Electric Company)

Curium

Lantheus Medical Imaging

Bayer

Bracco Imaging

Eczacibasi-Monrol Nuclear Products

Nordion (A Subsidiary of Sterigenics International)

Advanced Accelerator Applications (Aaa, Acquired By Novartis)

NTP Radioisotopes SOC Ltd

(Another brief information of 10 companies will be provided in a report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Nuclear Medicine Radioisotope Market, By Radioisotope

6.1 Technetium-99m (Tc-99m)

6.2 Thallium-201 (Tl-201)

6.3 Iodine (I-123)

6.4 Gallium-67 (Ga-67)

6.5 Fluorine-18

6.6 Rubidium-82 (Rb-82)

6.7 Other Types of Radioisotope

7. Global Nuclear Medicine Radioisotope Market, By Application

7.1 Oncology

7.2 Cardiology

7.3 Lymphoma

7.4 Thyroid

7.5 Neurology

7.6 Others

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Cardinal Health

9.2 Ge Healthcare (A Fully-Owned Subsidiary of General Electric Company)

9.3 Curium

9.4 Lantheus Medical Imaging

9.5 Bayer

9.6 Bracco Imaging

9.7 Eczacibasi-Monrol Nuclear Products

9.8 Nordion (A Subsidiary of Sterigenics International)

9.9 Advanced Accelerator Applications (Aaa, Acquired By Novartis)

9.10 NTP Radioisotopes SOC Ltd

(Another brief information of 10 companies will be provided in a report.)

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports